Stephens Consulting’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10
Closed -$604 1356
2025
Q1
$604 Buy
+10
New +$645 ﹤0.01% 884
2024
Q3
Sell
-24
Closed -$1.66K 547
2024
Q2
$1.66K Buy
+24
New +$1.75K ﹤0.01% 533

Other funds holding CNMD

Stephens Consulting's CNMD Position: Q2 2025 in Review

Stephens Consulting sold out of CONMED (CNMD) in Q2 2025, closing a stake of 10 shares — an estimated $604 sold.

Stephens Consulting first reported a position in CNMD in Q2 2024 and held it in 2 quarters. The position peaked at $1.66K in Q2 2024. 276 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • Stephens Consulting reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • Stephens Consulting sold 10 CONMED shares in Q2 2025, an estimated $604.
  • Stephens Consulting first reported a position in CONMED in Q2 2024 and held it in 2 quarters.
  • Stephens Consulting's CONMED position peaked at $1.66K in Q2 2024.
  • 276 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.